Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case-control study.
González S, Olszevicki S, Gaiano A, Salazar M, Regairaz L, Varela Baino AN, Bartel E, Varela T, González Martínez VV, Pesci S, Marín L, Irassar JI, Ceriani L, Garcia E, Kreplak N, Estenssoro E, Marsico F. González S, et al. Among authors: olszevicki s. Lancet Reg Health Am. 2023 Sep 28;27:100607. doi: 10.1016/j.lana.2023.100607. eCollection 2023 Nov. Lancet Reg Health Am. 2023. PMID: 37808936 Free PMC article.
Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study.
Castelli JM, Rearte A, Olszevicki S, Voto C, Del Valle Juarez M, Pesce M, Iovane AN, Paz M, Chaparro ME, Buyayisqui MP, Markiewicz MB, Landoni M, Giovacchini CM, Vizzotti C. Castelli JM, et al. Among authors: olszevicki s. BMJ. 2022 Nov 30;379:e073070. doi: 10.1136/bmj-2022-073070. BMJ. 2022. PMID: 36450402 Free PMC article.
Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study.
González S, Olszevicki S, Gaiano A, Baino ANV, Regairaz L, Salazar M, Pesci S, Marín L, Martínez VVG, Varela T, Ceriani L, Garcia E, Kreplak N, Navarro A, Estenssoro E, Marsico F. González S, et al. Among authors: olszevicki s. Lancet Reg Health Am. 2022 Sep;13:100316. doi: 10.1016/j.lana.2022.100316. Epub 2022 Jul 16. Lancet Reg Health Am. 2022. PMID: 35872665 Free PMC article.
Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina.
González S, Olszevicki S, Salazar M, Calabria A, Regairaz L, Marín L, Campos P, Varela T, Martínez VVG, Ceriani L, Garcia E, Kreplak N, Pifano M, Estenssoro E, Marsico F. González S, et al. Among authors: olszevicki s. EClinicalMedicine. 2021 Oct;40:101126. doi: 10.1016/j.eclinm.2021.101126. Epub 2021 Sep 12. EClinicalMedicine. 2021. PMID: 34541480 Free PMC article.
SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients.
Bizzotto J, Sanchis P, Abbate M, Lage-Vickers S, Lavignolle R, Toro A, Olszevicki S, Sabater A, Cascardo F, Vazquez E, Cotignola J, Gueron G. Bizzotto J, et al. Among authors: olszevicki s. iScience. 2020 Oct 23;23(10):101585. doi: 10.1016/j.isci.2020.101585. Epub 2020 Sep 23. iScience. 2020. PMID: 32989429 Free PMC article.